six months can help predict the onset of alzheimer's disease, and monitor the progression of the disease as well. gammaglobulin alzheimer's partnership study further examination of the safety, effectiveness and tolerability of ivig in mild to moderate alzheimer's disease patients. docosahexaenoic acid...